La computación neuromórfica es un paradigma computacional que intenta imitar el funcionamiento del cerebro, tanto en su arquitectura como en su dinámica. Con este enfoque, un nuevo tipo de hardware para computación neuromórfica ha sido desarrollado por un …
Nueva estructura para ordenadores que imitan el funcionamiento del cerebro humano Read More »
En una investigación reciente, se ha identificado una señal molecular anómala que es capaz de impulsar la formación de aneurismas hereditarios. El estudio revela cómo una proteína que se acumula en la pared de la aorta desencadena una cascada de se& …
Causa oculta de la formación de aneurismas hereditarios Read More »
Psychedelics are gaining momentum in depression, with one treating physician predicting that the drug class could “wipe out the SSRIs” if safety and durability hold up.
Psychedelics surge again as Compass, Definium provide more clinical validation Read More »
The FDA greenlit 26 novel therapies in the first half of 2026, including four for cancer and six for orphan indications. Meanwhile, AstraZeneca and Johnson and Johnson took home a combined 11 of the agency’s 79 total approvals, including supplemental nods.
Cancer, rare disease dominate FDA approvals in H1 2026 as AstraZeneca, J&J clean up Read More »
Johnson & Johnson expects U.S. physicians to perform the first procedures with the device this summer as it starts a phased commercial rollout.
J&J wins FDA approval for dual-energy ablation catheter Read More »
Saol Therapeutics is the latest biotech to resubmit for approval of a drug rejected under former FDA Commissioner Marty Makary, following REGENXBIO and Replimune.
Saol boards FDA’s resubmission boat, armed with new survival data Read More »
A former executive is claiming that the MA insurer recorded millions of dollars as capital expenditures that should have been operating expenses, inflating its value. Alignment strongly denied the allegations.
Whistleblower lawsuit accuses Alignment of accounting fraud Read More »
“We have all this data that’s available, but it’s actually not actionable because we don’t have a way to get it into clinical workflow,” said American Medical Associaion CEO Dr. John Whyte.
Physicians’ wearable data use hampered by reimbursement, workflow barriers: survey Read More »
The late-stage miss is “surprising,” Stifel analysts said, given that Wainua’s mechanism of silencing transthyretin protein expression has previously proven effective.
AstraZeneca, Ionis slip as ATTR-CM drug fails Phase 3 Read More »
An unnamed pharma filed a citizen petition in April seeking reforms to the way the FDA publicly releases rejection letters, alleging that the policy “contravenes decades of agency practice.”
FDA freezes CRL trove as ‘radical transparency’ push hits speedbump Read More »
